Medical News

RSS

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.

1 Feb 2011

Positive interim results from H5N1 Avian Influenza VLP vaccine Phase II human clinical trial

Medicago, a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate.

1 Feb 2011

OPKO Health acquires CURNA

OPKO Health, has acquired CURNA, a privately held company based in Jupiter, Florida, engaged in the discovery of new drugs for the treatment of a wide variety of illnesses, such as cancer, heart disease, metabolic disorders and genetic anomalies.

1 Feb 2011

Vanderbilt researchers announce multi-national collaboration on Alzheimer's disease genetics

Researchers at Vanderbilt University Medical Center, and across the globe, announced today a multi-national collaboration to discover and map all genes relating to Alzheimer's disease through the formation of the International Genomics of Alzheimer's Project.

1 Feb 2011

Savient announces pricing of $200 million 4.75% Convertible Senior Notes due 2018

Savient Pharmaceuticals, Inc. announced it has priced $200 million aggregate principal amount of 4.75% Convertible Senior Notes due 2018 (the "Notes") pursuant to an automatically effective registration statement filed with the Securities and Exchange Commission on January 31, 2011. In addition, Savient has granted the underwriters an option to purchase up to an additional $30 million aggregate principal amount of Notes, solely to cover over-allotments.

1 Feb 2011

Positive interim results from Medicago's Phase II clinical trial of H5N1 Avian Influenza VLP vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

1 Feb 2011

Kensey Nash second quarter revenue decreases to $17.4 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its second quarter ended December 31, 2010.

1 Feb 2011

DRC processors running Smith-Waterman algorithm set new world record

DRC Computer Corporation (DRC), the leading innovator of dynamically reconfigurable processors, announces that it has achieved 9.4 trillion cell updates per second (TCUPS) running the Smith-Waterman algorithm with Affine gap model on the latest DRC Accelium coprocessors.

1 Feb 2011

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.

1 Feb 2011

Orexigen, Takeda announce FDA's issue of complete response letter for Contrave NDA

Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the United States Food and Drug Administration (FDA) has issued a complete response letter dated January 31, 2011 regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.

1 Feb 2011

RTI fourth quarter net sales increases to $114.7 million

RTI International Metals, Inc.,, released results today for the fourth quarter and full year of 2010.

1 Feb 2011

First Edition: February 1, 2011

Today's health policy news focuses on analysis of Monday's ruling in which a federal court judge in Florida struck down the health law.

1 Feb 2011

John Snow sponsors MEDEA 2011 conference

John Snow, Inc. (JSI) is a proud sponsor of MEDEA 2011, a two-day conference (February 1 and 2) dedicated to improving the country of Georgia's health system by the year 2020. The conference, led by the government of Georgia, brings together high level Georgian and American health professionals to begin to solve some of the country's most pressing health problems.

1 Feb 2011

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

1 Feb 2011

Potential adverse effects of radiations on children's health

COST Action BM0704 is delighted to have as co-organisers of the Conference the International Commission on Non-Ionizing Radiation Protection (ICNIRP), the German Federal Office for Radiation Protection (BfS), the World Health Organization (WHO), the European Bioelectromagnetics Association (EBEA) and the European Society for Skin Cancer Prevention (EUROSKIN).

1 Feb 2011

Sensitive and confidential patient health records not adequately protected: Survey

The survey findings are being published today in a new report by the Ponemon Institute titled, Health Data at Risk in Development: A Call for Data Masking. The survey was sponsored by Informatica Corporation, the world's number one independent leader in data integration software.

1 Feb 2011

Scientists successfully crystallise key norovirus enzyme

With the number of norovirus infection cases rising across the country, scientists from the University of Southampton have successfully crystallised a key norovirus enzyme, which could help in the development of a norovirus treatment.

1 Feb 2011

Study establishes direct link between morphine abstinence and depressive-like symptoms

Opiate abuse is a chronic disorder and maintaining abstinence represents a major challenge for addicts.

1 Feb 2011

Kinetic Concepts fourth quarter net earnings increase 12% to $74.0 million

Kinetic Concepts, Inc. today reported fourth quarter and full year 2010 total revenue of $527.5 million and $2.02 billion, respectively, compared to $526.8 million and $1.99 billion in the corresponding periods of the prior year.

1 Feb 2011

AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma

AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).

1 Feb 2011

Medical News

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Positive interim results from H5N1 Avian Influenza VLP vaccine Phase II human clinical trial

OPKO Health acquires CURNA

Vanderbilt researchers announce multi-national collaboration on Alzheimer's disease genetics

Savient announces pricing of $200 million 4.75% Convertible Senior Notes due 2018

Positive interim results from Medicago's Phase II clinical trial of H5N1 Avian Influenza VLP vaccine

Kensey Nash second quarter revenue decreases to $17.4 million

DRC processors running Smith-Waterman algorithm set new world record

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

Orexigen, Takeda announce FDA's issue of complete response letter for Contrave NDA

RTI fourth quarter net sales increases to $114.7 million

First Edition: February 1, 2011

John Snow sponsors MEDEA 2011 conference

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Potential adverse effects of radiations on children's health

Sensitive and confidential patient health records not adequately protected: Survey

Scientists successfully crystallise key norovirus enzyme

Study establishes direct link between morphine abstinence and depressive-like symptoms

Kinetic Concepts fourth quarter net earnings increase 12% to $74.0 million

AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News